Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A brain stem glioma that occurs in an adult.
Biomarker and diagnostic research for adult brainstem glioma has been reported in the published literature.
4 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, procedural interventions, and other interventions. Pipeline includes 2 PHASE3, 1 PHASE2. Research is primarily sponsored by academic and government institutions.
145 publications have been identified in PubMed for adult brainstem glioma. Research spans Basic Science / Preclinical (41%), Review / Meta-Analysis (17%), and Diagnostic / Biomarker (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 59 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:52 AM UTC
Common questions about adult brainstem glioma
Research summaries | 24 | 17% |
Testing and diagnosis research | 20 | 14% |
New treatment approaches | 12 | 8% |
Disease patterns and progression | 11 | 8% |
Clinical study results | 10 | 7% |
Patient case studies | 8 | 6% |
Other research | 1 | 1% |
Kordyukova MY (2026). [PMID: 41828436](https://pubmed.ncbi.nlm.nih.gov/41828436/). *Int J Mol Sci*. [Review / Meta-Analysis]
Kerstens J (2026). [PMID: 41270249](https://pubmed.ncbi.nlm.nih.gov/41270249/). *Neurol Neuroimmunol Neuroinflamm*. [Epidemiology / Natural History]
Cai L (2026). [PMID: 41482238](https://pubmed.ncbi.nlm.nih.gov/41482238/). *Biochimica et biophysica acta. Reviews on cancer*. [Basic Science / Preclinical]
Meylan M (2026). [PMID: 41679299](https://pubmed.ncbi.nlm.nih.gov/41679299/). *Cell*. [Clinical Trial Publication]
Li C (2026). [PMID: 41903206](https://pubmed.ncbi.nlm.nih.gov/41903206/). *Neuro Oncol*. [Basic Science / Preclinical]
Maas SLN (2026). [PMID: 41663806](https://pubmed.ncbi.nlm.nih.gov/41663806/). *Nat Genet*. [Diagnostic / Biomarker]
Zhang PP (2026). [PMID: 41633974](https://pubmed.ncbi.nlm.nih.gov/41633974/). *Signal Transduct Target Ther*. [Basic Science / Preclinical]
Arce VM (2026). [PMID: 41651314](https://pubmed.ncbi.nlm.nih.gov/41651314/). *Critical reviews in oncology/hematology*. [Basic Science / Preclinical]
Piyadasa H (2026). [PMID: 41386224](https://pubmed.ncbi.nlm.nih.gov/41386224/). *Cancer cell*. [Basic Science / Preclinical]
T-Ardah M (2026). [PMID: 41531107](https://pubmed.ncbi.nlm.nih.gov/41531107/). *Immunology*. [Review / Meta-Analysis]
AI-curated news mentioning adult brainstem glioma
Updated Sep 16, 2026
Research highlights the role of H3K27M in promoting oligodendrocyte precursor cell (OPC) stemness and therapeutic vulnerability in brainstem glioma organoids. This discovery could inform future treatment strategies for this aggressive brain tumor.